Portfolio in graphics
|
Of the medicinal products in our portfolio slightly more are Rx than OTC:
|
The estimated relative time spent for the main categories of our tasks are as follows:
|
Portfolio in numbers
In the last > 20 years we have gained marketing authorisation approvals for medicinal products of the following therapeutic classes.
|
|
|
Licensed Products
Currently we are licence holder (MAH) of the following medicinal products, on behalf of our clients:
Sintrom 1mg, 4 mg, tablets |
Pevaryl(R), creme |
Esidrex(R) 25 mg, tablets |
Pevaryl(R), powder |
Digoxin-Juvisé 0.125, 0.25 mg, tablets |
Pevaryl(R), pump spray |
Digoxin-Juvisé, inj. sol. (i.v.) |
Dacepton(R) 10 mg/ml, inj. sol. |
Insidon(R), coated tablets |
Dacepton(R) 5 mg/ml, inj. sol. |
Entumin(R) 40 mg, tablets |
Oramorph 10 to 100 mg/5 mL, sol. |
Latuda(R) 20, 40 , 80, 120 mg, tablets |
Oramorph 20 mg/1 mL, sol. |
Ornibel, vaginal ring |
Abstral 100 to 800 ug, sublingiual tablets |
Flucelvax, inj. suspension |
Sylvant, 100mg and 400mg powder for inf. |
Scheriproct Salbe, Suppositorien |
Gyno-Pevaryl |
Pevisone, crème |
Dukoral, oral suspension |
Please refer to Swissmedic homepage for further information regarding the mentiones medicinal products under www.swissmedicinfo.ch